CLDI
CLDI
AMEX · Biotechnology

Calidi Biotherapeutics Inc

$0.19
-0.01 (-5.05%)
As of May 16, 2:33 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +25,355.5% upside
Low Target $29.39
Average Target $48.34
High Target $58.89
Current Price $0.19
Current
$0.19
Target
$48.34
$29.39 $48.34 avg $58.89
Scenario Analysis
Bear Case
$29.39
15,376.6%
Low target
Base Case
$48.34
+25,355.5%
Avg target
Bull Case
$58.89
+30,911.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
Target vs 52W High
$48.34
+151.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%